Study to Evaluate Biomarkers and Clinical Manifestations in Individuals With Glycogen Storage Disease Type III (GSD III)
NCT04574830 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 18
Last updated 2022-09-13
Summary
The primary objective of this study is to evaluate potential biomarkers of GSD III.
Conditions
- Glycogen Storage Disease Type III
Interventions
- OTHER
-
No Intervention
No Intervention
Sponsors & Collaborators
- lead INDUSTRY
Principal Investigators
-
Medical Director · Ultragenyx Pharmaceutical Inc
Eligibility
- Min Age
- 5 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-11-23
- Primary Completion
- 2022-06-30
- Completion
- 2022-06-30
Countries
- United States
Study Locations
More Related Trials
-
System Accuracy Evaluation of 6 CE-marked Blood Glucose Monitoring System Following ISO 15197:2013
NCT02531386 ·Status: COMPLETED ·Phase: NA
-
User Performance of the CONTOUR NEXT and CONTOUR TV3 Blood Glucose Monitoring System (BGMS)
NCT03730480 ·Status: COMPLETED ·Phase: NA
-
Clinical Evaluation of a Non-Invasive Hypoglycemia Detector in a Glycogen Storage Disease Population
NCT02338817 ·Status: TERMINATED
-
Effectiveness and Safety Study of the Abbott Sensor Based Glucose Monitoring Systems
NCT02283411 ·Status: COMPLETED ·Phase: NA
-
A Comparison Study of Prototype Continuous Glucose Sensors in the Intradermal and Subcutaneous Spaces
NCT01093833 ·Status: COMPLETED ·Phase: PHASE1
-
Study of an Interstitial Fluid Glucose Sensor
NCT05251116 ·Status: COMPLETED ·Phase: NA
-
Monitoring of Biomarkers by Portable Breath Gas Sensors: an Exploratory Study
NCT02685241 ·Status: COMPLETED
-
Correlation of CGM Metrics With OGTT and Pregnancy Outcomes in Pregnant Women With or Without a High Risk for GDM
NCT05537480 ·Status: UNKNOWN ·Phase: NA
-
Accuracy and Precision of the True Vie I3 Continuous Glucose Monitoring System: an Open Label, Multi-Center Trial
NCT05806554 ·Status: COMPLETED
-
The Effectiveness of Flash Glucose Monitoring System on Glycemic Control in Patients With New-onset Type 2 Diabetes
NCT04535830 ·Status: UNKNOWN ·Phase: PHASE4
-
Performance and Safety Evaluation of a Novel Non-invasive Glucose Monitoring Device and Evaluation of the Instructions for Use
NCT04033042 ·Status: COMPLETED ·Phase: NA
-
Observational Study to Evaluate the Effectiveness and Safety Study of the Dexcom G4™ Continuous Glucose Monitoring System
NCT01514305 ·Status: COMPLETED
-
Development of Pneumonia Due to Alveolar Glucose Levels in Systemic Hyperglycemia
NCT03577964 ·Status: UNKNOWN
-
PRediction Of Glycemic RESponse Study
NCT04881019 ·Status: ACTIVE_NOT_RECRUITING
-
Type 2 Diabetes Glucose Biomarker Study With a Continuous Glucose Monitoring System
NCT04529239 ·Status: COMPLETED
-
CGM Evaluation of Glucose Excursions in Basal Insulin Treated T2DM at Fasting Glucose Target
NCT01548222 ·Status: COMPLETED
-
The Early Diagnosis of Gestational Diabetes Mellitus Study
NCT02740283 ·Status: UNKNOWN ·Phase: NA
-
Performance Evaluation of Blood Glucose Monitoring System Using ISO Study Design
NCT01575080 ·Status: COMPLETED ·Phase: NA
-
Study to Evaluate a Prototype Non-Invasive BG Measurement System
NCT05023798 ·Status: UNKNOWN
-
N2-(1-carboxyethyl)-2'Deoxyguanosine (CEdG) a Potential Biomarker for Diabetes
NCT02065310 ·Status: COMPLETED ·Phase: NA
-
User Performance Evaluation of Contour® Next One, Accu-Chek® Aviva Connect, FreeStyle Freedom Lite, OneTouch® Verio and GlucoMen® Areo Blood Glucose Monitoring Systems Following ISO 15197:2013
NCT03033849 ·Status: COMPLETED ·Phase: NA
-
Evaluating System Accuracy of Blood Glucose Monitoring Systems for Self-testing in Managing Diabetes Mellitus
NCT01729546 ·Status: COMPLETED ·Phase: NA
-
Continuous Monitoring of Glycemic Variability to Predict Dys- and Hyperglycemia in Asymptomatic Type 1 Diabetes
NCT05777330 ·Status: RECRUITING ·Phase: NA
-
Biomarkers for Early Screening of Gestational Diabetes Mellitus
NCT05142020 ·Status: UNKNOWN
-
Accuracy of Lactate Meter in GSDIa
NCT06843330 ·Status: RECRUITING